Published in Arch Surg on September 01, 2004
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer (2011) 1.80
Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology (2009) 1.46
Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomarkers Prev (2012) 1.22
Obesity in cancer survival. Annu Rev Nutr (2012) 1.13
Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat (2013) 1.12
Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment. World J Surg Oncol (2008) 1.02
Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res (2005) 0.96
Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res (2010) 0.93
Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat (2013) 0.88
Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer. Surg Today (2014) 0.88
Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study. BMC Cancer (2015) 0.84
Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index. World J Gastroenterol (2008) 0.81
Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer. Cancer Med (2012) 0.80
Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma. Breast Cancer (Dove Med Press) (2014) 0.80
The impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemic. Gland Surg (2014) 0.79
Tamoxifen produces conditioned taste avoidance in male rats: an analysis of microstructural licking patterns and taste reactivity. Horm Behav (2009) 0.79
Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity. J Cell Mol Med (2009) 0.79
Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma. Int J Clin Exp Med (2015) 0.78
Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer. Int Semin Surg Oncol (2008) 0.77
Development of a mouse model of abdominal cutaneous flaps for breast reconstruction. PLoS One (2013) 0.75
Availability and utility of body mass index for population-based cancer surveillance. Cancer Causes Control (2007) 0.75
Obesity and Breast Cancer: Do Age, Race and Subtype Matter? BAOJ Cancer Res Ther (2016) 0.75
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol (2002) 13.81
Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med (2011) 12.52
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med (2010) 5.17
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses. Breast Cancer Res Treat (2008) 4.84
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol (2012) 4.47
Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol (2010) 4.23
Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care (2005) 1.56
Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomarkers Prev (2012) 1.22
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. J Clin Oncol (2003) 1.07
Impact of reproductive factors and lactation on breast carcinoma in situ risk. Int J Cancer (2004) 0.99
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J Clin Oncol (2004) 0.95
The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin. Br J Haematol (2011) 0.93
Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base. Ann Surg Oncol (2013) 0.85
Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer. Int J Radiat Oncol Biol Phys (2002) 0.81
Does hormone therapy counter the beneficial effects of physical activity on breast cancer risk in postmenopausal women? Cancer Causes Control (2011) 0.77